JP2022521390A5 - - Google Patents

Info

Publication number
JP2022521390A5
JP2022521390A5 JP2021548207A JP2021548207A JP2022521390A5 JP 2022521390 A5 JP2022521390 A5 JP 2022521390A5 JP 2021548207 A JP2021548207 A JP 2021548207A JP 2021548207 A JP2021548207 A JP 2021548207A JP 2022521390 A5 JP2022521390 A5 JP 2022521390A5
Authority
JP
Japan
Application number
JP2021548207A
Other languages
Japanese (ja)
Other versions
JPWO2020169819A5 (https=
JP2022521390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/054652 external-priority patent/WO2020169819A1/en
Publication of JP2022521390A publication Critical patent/JP2022521390A/ja
Publication of JP2022521390A5 publication Critical patent/JP2022521390A5/ja
Publication of JPWO2020169819A5 publication Critical patent/JPWO2020169819A5/ja
Priority to JP2024181817A priority Critical patent/JP2025019061A/ja
Pending legal-status Critical Current

Links

JP2021548207A 2019-02-21 2020-02-21 術後有害事象の診断または予後 Pending JP2022521390A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024181817A JP2025019061A (ja) 2019-02-21 2024-10-17 術後有害事象の診断または予後

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19020082 2019-02-21
EP19020082.4 2019-02-21
PCT/EP2020/054652 WO2020169819A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024181817A Division JP2025019061A (ja) 2019-02-21 2024-10-17 術後有害事象の診断または予後

Publications (3)

Publication Number Publication Date
JP2022521390A JP2022521390A (ja) 2022-04-07
JP2022521390A5 true JP2022521390A5 (https=) 2023-03-01
JPWO2020169819A5 JPWO2020169819A5 (https=) 2023-03-01

Family

ID=65529223

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021548207A Pending JP2022521390A (ja) 2019-02-21 2020-02-21 術後有害事象の診断または予後
JP2024181817A Pending JP2025019061A (ja) 2019-02-21 2024-10-17 術後有害事象の診断または予後

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024181817A Pending JP2025019061A (ja) 2019-02-21 2024-10-17 術後有害事象の診断または予後

Country Status (7)

Country Link
US (1) US20220187313A1 (https=)
EP (1) EP3928099A1 (https=)
JP (2) JP2022521390A (https=)
CN (1) CN113424065A (https=)
BR (1) BR112021016597A2 (https=)
CA (2) CA3295270A1 (https=)
WO (1) WO2020169819A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240221958A1 (en) * 2021-04-30 2024-07-04 Roche Diagnostics Operations, Inc. Pct marker panels for early detection of sepsis
WO2022229438A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Il6 marker panels for early detection of sepsis
EP4351636A4 (en) * 2021-06-02 2025-04-23 Washington University Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
JP2023111774A (ja) * 2022-01-31 2023-08-10 国立研究開発法人国立循環器病研究センター 再灌流療法の適用を決定するバイオマーカー
KR20250077078A (ko) * 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심장 트로포닌 수치를 예측하기 위한 방법 및 장치
KR20250077079A (ko) 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심근 손상을 예측하기 위한 방법 및 장치
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement
KR102750097B1 (ko) * 2024-07-29 2025-01-03 가천대학교 산학협력단 심혈관 시술 이후 환자의 합병증 예측 및 추적 관리 시스템 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
JP5711131B2 (ja) * 2008-10-07 2015-04-30 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最初の有害事象の予測のためのバイオマーカー
WO2014018464A1 (en) * 2012-07-23 2014-01-30 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
GB201402293D0 (en) * 2014-02-11 2014-03-26 Secr Defence Biomarker signatures for the prediction of onset of sepsis
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
JP6855118B2 (ja) * 2017-03-14 2021-04-07 東ソー株式会社 全身状態の良不良を評価するための情報を提供する方法及び測定試薬
EP3438668A1 (en) * 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2022521390A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)